MedTrace Logo

Different Dosing Regimens of STOP-AST

NCT06124703 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 162

Last updated 2023-11-13

No results posted yet for this study

Summary

The goal of this clinical trial is to learn about the different dose regimens of the efficacy of oral steroids in the acute tinnitus population. Participants will receive different appropriate dosages of prednisone tablets and oral Ginkgo Biloba tablets.

Conditions

Interventions

DRUG

Prednisone tablet

Prednisone acetate tablet (5 mg prednisone acetate per tablet) was provided

DRUG

Ginkgo Biloba Extract

Ginkgo biloba extract (EGb) is a compound drug derived from Ginkgo biloba trees native to China.

Sponsors & Collaborators

  • Eye & ENT Hospital of Fudan University

    lead OTHER

Principal Investigators

  • Shan Sun · Eye and ENT Hospital of Fudan University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-10
Primary Completion
2024-02-10
Completion
2024-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06124703 on ClinicalTrials.gov